Platelet serotonin, a possible marker for familial autism

Area of Science:

• Neuroscience
• Genetics
• Developmental Psychology

Background:

• Serotonin (5HT) is a neurotransmitter implicated in various neurological functions.
• Altered 5HT levels have been observed in some individuals with autism spectrum disorder (ASD).
• Family history of ASD or Pervasive Developmental Disorder (PDD) may indicate a genetic predisposition.

Purpose of the Study:

• To investigate serotonin (5HT) levels in platelet-rich plasma of autistic subjects.
• To examine the association between 5HT levels and the presence of affected siblings (autism or PDD).
• To determine if 5HT levels correlate with genetic liability to autism.

Main Methods:

• Measurement of serotonin (5HT) levels in platelet-rich plasma.
• Comparison of 5HT levels across three groups: autistic subjects with affected siblings, autistic subjects without affected siblings, and neurotypical controls.
• Statistical analysis adjusted for sex, age, and IQ.

Main Results:

• Autistic subjects with affected siblings exhibited significantly higher 5HT levels compared to autistic subjects without affected siblings.
• Autistic subjects without affected siblings showed significantly higher 5HT levels than normal controls.
• The observed differences in 5HT levels remained statistically significant after controlling for covariates.

Conclusions:

• Elevated platelet serotonin (5HT) levels are associated with autism spectrum disorder.
• The findings suggest a potential link between 5HT dysregulation and the genetic liability to autism.
• Family history of autism or PDD may be associated with increased 5HT levels in autistic individuals.